This article not subject to U.S. Copyright. Published 2019 by the American Chemical Society. Noel T. Southall Abstract We report our experience working with the US Food and Drug Administration…
The post Freedom of Information Act Access to an Investiga…
Freedom of Information Act Access to an Investigational New Drug Application Read Post »
This is a guest post by Shamil Gizatullin, Gowling WLG (International) Inc. [email protected] Although it has become harder to obtain patent-term extensions for drugs, pesticides or agricultural chemicals, a careful…
The post Getting the…
Getting the most out of pharmaceutical patent-term extensions in Russia Read Post »
Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch can help you replace or supplement your current solutions with:…
The post Switching to DrugPatentWatch appeared fir…
Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government…
The post Government as the First Investor in B…
Government as the First Investor in Biopharmaceutical Innovation Read Post »
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy…
The post Bloomberg and Drug PatentWatch: A “Perfect Storm” A…
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs Read Post »
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy…
The post Bloomberg and Drug PatentWatch: A “Perfect Storm” A…
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs Read Post »
This paper was originally published by Melek Simsek, Berrie Meijer, Adriaan A. van Bodegraven, Nanne K.H. de Boer, and Chris J.J. Mulder in Drug Discovery Today under a Creative Commons…
The post Finding hidden treasures in old drugs: the challenges an…
When drug patents expire, billions of dollars in revenues can disappear overnight as competitors enter the market. Accordingly, many investors focus on drug patents when evaluating drug companies. But, there…
The post Investing in Drug Companies? Here …
Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider Read Post »
Just because a drug has received FDA approval does not mean that it is available in the marketplace. But, why would a company go through all the trouble and expense…
The post Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will…
The USPTO Office of the Chief Economist has releases a comprehensive set of patent litigation data files for public use. The Patent Litigation Dataset has been updated as of December…
The post Free Patent Litigation Docket Reports Data appeared first o…